Nucleome Therapeutics appoints Dr Michelle Morrow as chief scientific officer
Nucleome Therapeutics has appointed Dr Michelle Morrow as chief scientific officer as the company advances its pipeline of potential medicines for inflammatory…
Nucleome Therapeutics has appointed Dr Michelle Morrow as chief scientific officer as the company advances its pipeline of potential medicines for inflammatory…
Children with epilepsy have a higher risk of also having autism spectrum disorder (ASD). A new study in Developmental Medicine & Child…